Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer

Yuqin Ding; Kaijing Ding; Hongdan Qian; Xingfei Yu; Dehong Zou; Hongjian Yang; Wenju Mo; Xiangming He; Fanrong Zhang; Chengdong Qin; Yurong Zheng; Xiaowen Ding

首页> 外文期刊>PLoS One >Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer

【24h】

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer

机译：对雌激素受体，孕酮受体和Ki-67表达的影响的影响，在乳腺癌中预先和后期后曲目化疗

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose To investigate whether estrogen receptor (ER), progesterone receptor (PR) and Ki-67 expression discordance before and after neoadjuvant chemotherapy (NAC) correlates with prognosis and treatment of breast cancer patients.

机译：目的探讨雌激素受体（ER），孕酮受体（PR）和KI-67表达在Neoadjuvant化疗（NAC）之前和之后的表达，与乳腺癌患者的预后和治疗相关联。

著录项

来源
《PLoS One》 |2020年第4期|共13页
作者
Yuqin Ding; Kaijing Ding; Hongdan Qian; Xingfei Yu; Dehong Zou; Hongjian Yang; Wenju Mo; Xiangming He; Fanrong Zhang; Chengdong Qin; Yurong Zheng; Xiaowen Ding;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy. [J] . Kasami M, Uematsu T, Honda M, The Breast : . 2008,第5期

机译：乳腺癌新辅助化疗前后的雌激素受体，孕激素受体和Her-2状态的比较。
2. Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer [J] . Qin Qinghong, Gao Fangfang, Jiang Wei, 中华医学杂志（英文版） . 2014,第018期

机译：新辅助化疗对乳腺癌中雌激素受体，孕激素受体，人表皮生长因子受体2和Ki-67表达的影响
3. Discordance of Estrogen & Progesterone Receptors After Neoadjuvant Chemotherapy in Breast Cancer- an Indian Study [J] . Aravindh Sivanandan Anand, Sandeep Thekoot Velayudhan Indian journal of surgical oncology . 2016,第3期

机译：乳腺癌新辅助化疗后雌激素和孕激素受体的不一致-印度研究
4. Immunohistochemistry applications in breast carcinoma: The Hypoxia Inducible Factor lα, Estrogen Receptor, Progesterone Receptor and HER2 expression before and after neoadjuvant chemotherapy [C] . Zuofeng Zhang, Yunai Liang, Chunhua Zhang, Technical Congress on Resources, Environment and Engineering . 2016

机译：免疫组织化学在乳腺癌中的应用：缺氧诱导因子Lα，雌激素受体，孕酮受体和Neoadjuvant化疗前后和Her2表达
5. Studies on the roles of Bcl-2 and caspases in hormone-induced active cell death in estrogen receptor- and progesterone receptor-expressing breast cancer cells. [D] . Gaddy, Virgil Thomas, Jr. 2007

机译：Bcl-2和胱天蛋白酶在激素诱导表达雌激素受体和孕激素受体的乳腺癌细胞中的作用研究。
6. Impact on survival of estrogen receptor progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer [O] . Yuqin Ding, Kaijing Ding, Hongdan Qian, 2020

机译：对雌激素受体孕酮受体和Ki-67表达的生存的影响不用于乳腺癌中的新辅助化疗预先和后期后化学疗法
7. Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer [O] . Yuqin Ding, Kaijing Ding, Hongdan Qian, 2020

机译：对雌激素受体，孕酮受体和Ki-67表达的生存的影响，不用于乳腺癌中的新辅助化疗预先和后期后化学疗法

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅